Comparing Accelerated and Conventional Radiotherapy for Head and Neck Cancer
Author Information
Author(s): Awwad H K, Lotayef M, Shouman T, Begg A C, Wilson G, Bentzen S M, El-Moneim H Abd, Eissa S
Primary Institution: National Cancer Institute, University of Cairo
Hypothesis
Can accelerated hyperfractionation improve postoperative radiotherapy outcomes in locally advanced head and neck cancer?
Conclusion
Accelerated hyperfractionation improves local control rates but does not provide a survival advantage compared to conventional fractionation.
Supporting Evidence
- The 3-year locoregional control rate was significantly better in the accelerated hyperfractionation group (88%) compared to the conventional fractionation group (57%).
- Accelerated hyperfractionation did not show a significant survival advantage over conventional fractionation (60% vs 46%).
- A rapid tumor growth was associated with a higher risk of distant metastases.
Takeaway
This study looked at two ways to give radiation to patients after surgery for head and neck cancer. One way worked better for keeping the cancer from coming back, but both ways had similar survival rates.
Methodology
Patients were randomized to receive either accelerated hyperfractionation or conventional fractionation after surgery, with various measures taken to assess treatment outcomes.
Limitations
The study did not find Tpot to be a reliable predictor for treatment outcomes, limiting its use in patient selection for accelerated hyperfractionation.
Participant Demographics
Patients were less than 65 years old with squamous cell carcinoma of the oral cavity, larynx, and hypopharynx.
Statistical Information
P-Value
0.01
Confidence Interval
95% CI: 1.87 to 9.36
Statistical Significance
p=0.01
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website